Skip to content

Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity

A Retrospective Analysis of Possible Association Between Severe Pregnancy Complications and Elevated Factor VIII Plasma Activity.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00573118
Enrollment
100
Registered
2007-12-13
Start date
2000-01-31
Completion date
2008-01-31
Last updated
2007-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Fetal Death, Intrauterine Fetal Growth Restriction, Placental Abruption, Preeclampsia, Pregnancy Complications

Keywords

Pregnancy complications: preeclampsia , severe IUGR , IUFD or placental abruption (n = 5).

Brief summary

Congenital and acquired thrombophilia were identified as risk factors for thrombosis in systemic vessels.Thrombophilias have also been recently found to be associated with preeclampsia, intrauterine fetal growth restriction (IUGR), placental abruption, intrauterine fetal death (IUFD) and repeated pregnancy loss.These severe pregnancy complications are thought to result from thrombotic events occurring in the uteroplacental circulation. Accumulating data have established an association between elevated plasma activity of factor VIII and thrombosis although the mechanism is still not defined and elevated factor VIII activity is now regarded as being equivalent to thrombophilia. We intend to investigatthe association between factor VIII levels and severe pregnancy complications which are considered to result from placental vascular pathology, i.e., preeclampsia, IUGR, placental abruption and IUFD. We hypothezise that the prevalence of elevated factor 8 will be higher among women with pregnancy complications compared to controls.

Interventions

None listed

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women who had either normal pregnancy or complicated pregnancy.

Exclusion criteria

* Other causes of pregnancy complication such as infections, anomalies and fetal malformations

Design outcomes

Primary

MeasureTime frame
prevalenc of elevated factor VIIIRETROSPECTIVE

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026